Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,054,969 | 1,023,825 | 901,983 | 1,011,935 | 972,140 |
| Cost of Goods | 111,611 | 109,902 | 95,487 | 107,243 | 102,153 |
| Gross Profit | 943,358 | 913,923 | 806,496 | 904,692 | 869,987 |
| Operating Expenses | 683,759 | 715,382 | 740,776 | 782,438 | 697,748 |
| Operating Income | 260,210 | 199,443 | 66,207 | 122,497 | 172,392 |
| Interest Expense | 58,702 | 62,023 | 66,116 | 70,324 | 71,497 |
| Other Income | -986 | 495 | -3,040 | 8,892 | -1,251 |
| Pre-tax Income | 200,522 | 137,915 | -2,949 | 61,065 | 99,644 |
| Income Tax | -14,533 | -30,653 | 11,669 | -33,089 | -47,176 |
| Net Income Continuous | 215,055 | 168,568 | -14,618 | 94,154 | 146,820 |
| Net Income | $215,055 | $168,568 | $-14,618 | $94,154 | $146,820 |
| EPS Basic Total Ops | 3.50 | 2.68 | -0.23 | 1.50 | 2.33 |
| EPS Basic Continuous Ops | 3.50 | 2.68 | -0.23 | 1.50 | 2.33 |
| EPS Diluted Total Ops | 3.42 | 2.49 | -0.23 | 1.40 | 2.14 |
| EPS Diluted Continuous Ops | 3.40 | 2.42 | -0.23 | 1.34 | 2.06 |
| EPS Diluted Before Non-Recurring Items | 5.86 | 4.67 | 1.98 | N/A | N/A |
| EBITDA(a) | $425,442 | $362,478 | $229,590 | $281,698 | $334,950 |